arginine has been researched along with Diabetic Foot in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, KY; Daher, GS; Goyal, N; Wells, JW | 1 |
| Béquet-Romero, M; Berlanga Acosta, J; Fabelo-Martínez, A; Fernández-Mayola, M; Figueroa-Martínez, A; García-Ojalvo, A; Guillén-Nieto, G; Mendoza-Marí, Y | 1 |
| Corcoran, MA; Moore, ZE; Patton, D | 1 |
| Abd-El-Aziz, M; Al-Bayoumy, A; Amer, T; El-Nahas, M; Kyrillos, FA; Motawea, M | 1 |
| Chen, HY; Chen, KH; Huang, CH; Huang, YY; Hung, SY; Lin, CN; Lin, CW; Tsai, JS; Yang, HM; Yeh, JT | 1 |
| Armstrong, DG; Baggs, GE; Cervantes, HL; Driver, VR; Furst, GJ; Hanft, JR; Lazaro-Martinez, JL; May, PE; Moore, MF; Nelson, JL; Reyzelman, AM; Smith, AP; Snyder, RJ; Vayser, DJ; Voss, AC | 1 |
| Cimsit, M; Gurdol, F; Kocak, H; Oner-Iyidogan, Y; Sengun, S; Yalcinkaya-Demirsoz, S | 1 |
| Boulton, AJ; Dang, C; Jude, EB | 1 |
| Barinov, EF; Barinova, ME; Sulaieva, OM | 1 |
| Barinov, EF; Barinova, ME; Sulaeva, ON | 1 |
| Halushko, OA; Shlapak, IP | 1 |
| El-Mesallamy, HO; Ezzat, OA; Hamdy, NM; Reda, AM | 1 |
| Federici, A; Federici, G; Milani, M | 1 |
| Belcaro, G; Cesarone, MR; Ciammaichella, G; Dugall, M; Hosoi, M; Ippolito, E; Luzzi, R | 1 |
| Cilci, M; Demirci, MC; Gunduz, M; Gungor, O; Sipahi, S; Tamer, A | 1 |
| Fossel, ET | 1 |
| Arana, V; González, A; Méndez, JD; Méndez, V; Paz, Y | 1 |
| Barinova, ME; Sulaieva, OM | 1 |
2 review(s) available for arginine and Diabetic Foot
| Article | Year |
|---|---|
A Systematic Review of Oral Nutritional Supplement and Wound Healing.
Topics: Adult; Arginine; Diabetic Foot; Humans; Minerals; Vitamins; Wound Healing | 2022 |
Nutritional interventions for treating foot ulcers in people with diabetes.
Topics: Arginine; Diabetic Foot; Dietary Proteins; Dietary Supplements; Fatty Acids, Omega-3; Female; Glutamine; Humans; Magnesium; Magnesium Oxide; Male; Middle Aged; Minerals; Randomized Controlled Trials as Topic; Trace Elements; Valerates; Vitamins; Wound Healing; Zinc Sulfate | 2020 |
5 trial(s) available for arginine and Diabetic Foot
| Article | Year |
|---|---|
Effect of oral nutritional supplementation on wound healing in diabetic foot ulcers: a prospective randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Ankle Brachial Index; Arginine; Diabetic Foot; Dietary Supplements; Double-Blind Method; Female; Glutamine; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome; Valerates; Wound Healing | 2014 |
Effect of L-arginine on the microcirculation in the neuropathic diabetic foot in Type 2 diabetes mellitus: a double-blind, placebo-controlled study.
Topics: Arginine; Diabetes Mellitus, Type 2; Diabetic Foot; Double-Blind Method; Female; Humans; Male; Microcirculation; Middle Aged; Placebos; Treatment Outcome | 2010 |
[Application of tivortin in complex treatment of diabetic foot syndrome].
Topics: Adult; Aged; Aged, 80 and over; Arginine; Carbohydrate Metabolism; Combined Modality Therapy; Diabetic Foot; Female; Glycated Hemoglobin; Humans; Leukocyte Count; Male; Middle Aged; Pain, Postoperative; Severity of Illness Index; Treatment Outcome | 2011 |
An urea, arginine and carnosine based cream (Ureadin Rx Db ISDIN) shows greater efficacy in the treatment of severe xerosis of the feet in Type 2 diabetic patients in comparison with glycerol-based emollient cream. A randomized, assessor-blinded, controll
Topics: Administration, Topical; Adult; Aged; Arginine; Carnosine; Diabetes Mellitus, Type 2; Diabetic Foot; Drug Combinations; Emollients; Female; Foot Dermatoses; Glycerol; Humans; Male; Middle Aged; Severity of Illness Index; Single-Blind Method; Skin Cream; Treatment Outcome; Urea | 2012 |
Improvement of temperature and flow in feet of subjects with diabetes with use of a transdermal preparation of L-arginine: a pilot study.
Topics: Administration, Cutaneous; Arginine; Diabetic Foot; Double-Blind Method; Foot; Humans; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Regional Blood Flow; Skin Temperature | 2004 |
11 other study(ies) available for arginine and Diabetic Foot
| Article | Year |
|---|---|
Systemic translation of locally infiltrated epidermal growth factor in diabetic lower extremity wounds.
Topics: Aged; Arginine; Biomarkers; Blood Sedimentation; C-Reactive Protein; Chemokine CCL3; Cytokines; Diabetic Foot; Epidermal Growth Factor; fas Receptor; Female; Humans; Injections, Intralesional; Lysine; Male; Middle Aged; Nitrates; Nitrites; Receptor for Advanced Glycation End Products; Recombinant Proteins; Wound Healing | 2019 |
Plasma levels of Asymmetric Di Methyl Arginine and endothelial dysfunction in diabetic subjects with neuropathic foot ulcer.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arginine; Diabetes Mellitus; Diabetic Foot; Endothelium, Vascular; Humans | 2021 |
Amino acids and wound healing in people with limb-threatening diabetic foot ulcers.
Topics: Aged; Aged, 80 and over; Amino Acids; Amputation, Surgical; Arginine; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Foot; Female; Hospitalization; Humans; Isoleucine; Leucine; Male; Threonine; Treatment Outcome; Wound Healing | 2019 |
Collagen synthesis, nitric oxide and asymmetric dimethylarginine in diabetic subjects undergoing hyperbaric oxygen therapy.
Topics: Aged; Arginine; Biomarkers; Collagen; Diabetic Foot; Female; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Nitric Oxide; Peptide Fragments; Procollagen; Time Factors; Treatment Outcome; Wound Healing | 2010 |
[Molecular mechanisms of the iNOS regulation disorders in monocytes of patients with diabetic foot syndrome].
Topics: Aged; Arginine; Cells, Cultured; Diabetic Foot; Enzyme Inhibitors; Female; Humans; Lipopolysaccharides; Male; Middle Aged; Monocytes; Necrosis; Nitric Oxide; Nitric Oxide Synthase Type II | 2010 |
[Blood monocytic L-arginine metabolic changes in diabetic foot syndrome].
Topics: Adult; Aged; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Arginase; Arginine; Diabetic Foot; Female; Humans; Lipopolysaccharides; Male; Middle Aged; Monocytes; Nitric Oxide Synthase Type II; Phosphoric Diester Hydrolases; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Receptor, Angiotensin, Type 1 | 2010 |
Levels of soluble advanced glycation end product-receptors and other soluble serum markers as indicators of diabetic neuropathy in the foot.
Topics: Aged; Arginine; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Foot; Diabetic Neuropathies; Glycated Hemoglobin; Humans; Male; Middle Aged; Nitric Oxide; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Solubility | 2011 |
Product evaluation of Ureadin Rx Db (ISDIN) for prevention and treatment of mild-to-moderate xerosis of the foot in diabetic patients. Prevention of skin lesions due to microangiopathy.
Topics: Administration, Cutaneous; Arginine; Carnosine; Dermatologic Agents; Diabetic Angiopathies; Diabetic Foot; Drug Combinations; Eczema; Female; Humans; Laser-Doppler Flowmetry; Lipids; Male; Microcirculation; Middle Aged; Pilot Projects; Pressure; Product Surveillance, Postmarketing; Skin; Surveys and Questionnaires; Ultrasonography; Urea | 2012 |
The effect of oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine on wound healing: a retrospective analysis of diabetic haemodialysis patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Arginine; Diabetic Foot; Dietary Supplements; Female; Glutamine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome; Valerates | 2013 |
Healing of diabetic foot ulcers in L-arginine-treated patients.
Topics: Arginine; Diabetic Foot; Humans; Wound Healing | 2004 |
[State of intracellular signaling systems in endothelial dysfunction].
Topics: Adrenergic alpha-Agonists; Adult; Aged; Arginine; Clonidine; Diabetic Foot; Endothelium, Vascular; Female; Humans; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Platelet Aggregation; Receptors, Adrenergic; Signal Transduction | 2007 |